Entorhinal Cortex Layer II neurons represent a critical gateway between the neocortex and hippocampus, playing essential roles in memory, spatial navigation, and episodic memory formation. These neurons are among the first to exhibit pathological changes in Alzheimer's disease, making them a focal point for understanding early neurodegeneration mechanisms[1].
EC Layer II is primarily composed of stellate cells and pyramidal neurons that project to the dentate gyrus via the perforant path. These cells express distinctive molecular markers including Reelin, WFS1 (wolframin), and SLC30A1 (zinc transporter)[2].
| Property | Value |
|---|---|
| Category | Entorhinal Cortex |
| Location | Entorhinal cortex layer II, lateral entorhinal area |
| Cell Types | Stellate cells, pyramidal neurons |
| Primary Neurotransmitter | Glutamate |
| Key Markers | Reelin+, WFS1+, SLC30A1+, calbindin+ |
| Afferents | Perirhinal cortex, postrhinal cortex, lateral entorhinal area |
| Efferents | Dentate gyrus (molecular layer), CA1 stratum lacunosum-moleculare |
EC Layer II neurons form the primary gateway for neocortical information entering the hippocampal formation. All cortical inputs to the dentate gyrus and CA regions must pass through these neurons, making them critical for:
The entorhinal grid cell system provides a neural substrate for spatial representation:
EC Layer II is the most vulnerable region in early AD, showing tau neurofibrillary tangles before any other cortical area (Braak Stage I)[4]:
| Feature | Description |
|---|---|
| Earliest tau pathology | Layer II stellate cells show NFT formation before CA1/pyramidal |
| Reelin loss | Decreased Reelin+ neurons correlate with cognitive decline |
| Grid cell disruption | Spatial navigation deficits precede memory impairment |
| Perforant path degeneration | Loss of EC→DG projection disrupts memory encoding |
Mechanistic cascade in AD:
Key publications:
EC Layer II neurons are hyperactive in temporal lobe epilepsy, showing:
While primarily affecting dopaminergic neurons, PD shows:
| Cell Type | Primary Pathology | First Affected | Key Markers |
|---|---|---|---|
| EC Layer II stellate | Tau NFTs | Braak I | Reelin+, WFS1+ |
| Locus coeruleus neurons | Tau NFTs | Braak I-II | TH+, DBH+ |
| Dorsal raphe serotonin | Lewy bodies | LB Stage II | TPH2+ |
| Substantia nigra DA | Lewy bodies | LB Stage III | TH+, Pitx3+ |
](/mechanisms/grid-cells
--perforant-pathway
--dentate-gyrus
--reelin-signaling
--wfs1-gene)## Background
The study of Entorhinal Cortex Layer Ii Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Khan et al. Selective vulnerability of entorhinal cortex in AD (2014). 2014. ↩︎
Mattson & Modak, Reelin and entorhinal cortex function (2014). 2014. ↩︎
Hafting et al. Microstructure of a spatial map in the entorhinal cortex (2005). 2005. ↩︎
[Braak & Braak, Neurofibrillary changes in AD (1991)](https://doi.org/10.1016/0197-4580(91). 1991. ↩︎